Prostate Cancer Clinical Trials in Kansas City, MO

Prostate Cancer Clinical Trials in Kansas City, MO

View the best 10 prostate cancer medical studies in Kansas City, Missouri. Access promising new therapies by applying to a Kansas City-based Prostate Cancer clinical trial.

Trials in Kansas City, Missouri

Here are the top 10 medical studies for prostate cancer in Kansas City, Missouri

Image of UC San Diego Moores Cancer Center in La Jolla, United States.

Olaparib +1 More

PARP Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing olaparib, a PARP inhibitor, as a possible treatment for metastatic castration-resistant prostate cancer. The trial will also study the best dose of olaparib and the side effects of the combination treatment.
Image of Los Angeles County-USC Medical Center in Los Angeles, United States.

Radium-223 Dichloride

Radiopharmaceutical

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug, M3814, to see if it can help treat prostate cancer that has spread to other parts of the body and is no longer responsive to hormonal therapy. M3814 will be given alone or in combination with other drugs, and the goal is to see if it can lower the chances of the cancer growing or spreading.
Image of University of Kansas Medical Center/ Cancer Center in Kansas City, United States.

Hypofractionated Radiation

Radiation Therapy

Recruiting1 award
This trial is testing if a new way of treating prostate cancer, ultra-hypofractionation, is effective and has less urinary side effects.
Image of University of Alabama at Birmingham in Birmingham, United States.

Enzalutamide +1 More

Antiandrogen

Recruiting1 awardPhase 3
This trial will test whether adding the drug enzalutamide to leuprolide helps patients with high-risk prostate cancer that has come back after surgery or radiotherapy.
Image of Moffitt Cancer Center in Tampa, United States.

KPT-8602

XPO1 inhibitor

Recruiting1 awardPhase 1 & 2
This trial will assess the safety, tolerability, and preliminary efficacy of KPT-8602, an oral XPO1 inhibitor, in patients with relapsed/refractory multiple myeloma, metastatic colorectal cancer, metastatic castration resistant prostate cancer, higher risk myelodysplastic syndrome, acute myeloid leukemia, and newly diagnosed intermediate/high-risk MDS.
Image of Arizona Center for Cancer Care - Gilbert in Gilbert, United States.

ProstAtak® Immunotherapy

Cancer Vaccine

Recruiting1 awardPhase 3
This trial is testing ProstAtak® immunotherapy with radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak® kills cancer cells and helps the immune system learn to attack any remaining cancer cells, potentially improving treatment outcomes.
Image of Vancouver General Hospital in Vancouver, Canada.

Randomized - Intervention

Recruiting1 award1 criteria
This trial will study whether modifying risk factors can reduce the risk of prostate cancer progression.
Image of Cedars Sinai in Los Angeles, United States.

177Lu-J591 +1 More

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial tests a new drug to see if it's effective against prostate cancer when used with ketoconazole and hydrocortisone.
Image of City of Hope in Duarte, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial is testing a new cancer treatment that uses a fusion protein and an anti-PD1 antibody. There will be four cohorts of patients with different types of cancer, all of whom have not responded well to other treatments.
Image of City of Hope National Medical Center in Duarte, United States.

AMG 509

Protein Kinase Inhibitor

Recruiting1 awardPhase 1
This trial is testing a new drug called AMG 509 in adults to see if it is safe and to find the best dose. The study will monitor how people react to different doses.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.